Purdue Pharma to Plead Guilty, Pay $8.3 Billion to Resolve Federal Probes over Opioid Marketing
- October 23, 2020
Purdue Pharma L.P., which manufactures OxyContin, agreed to pay $8.3 million and plead guilty to three felony counts to resolve multi-year federal criminal and civil investigations into the company’s marketing practices for the addictive painkiller, the Department of Justice announced October 21.
ARTICLE TAGS
You must be logged in to access this content.